One-quarter to one-third of ischemic strokes have no established mechanism after standard
diagnostic evaluation and are classified as embolic stroke of undetermined source (ESUS) …

Currently 1 in 10 patients with ischemic stroke have comorbid cancer, and this frequency is
expected to increase with continued advances in cancer therapeutics prolonging median …

Systemic cancer and ischemic stroke are common conditions and two of the most frequent
causes of death among the elderly. The association between cancer and stroke has been …

Background and Objectives To explore clinical and safety outcomes of patients with acute
ischemic stroke (AIS) and active cancer after endovascular treatment (EVT). Methods Using …

The histological features of thrombus in stroke patients with cancer are not well known.
Using immunohistochemical staining of thrombi retrieved during mechanical thrombectomy …

Abstract Introduction Approximately 5–10% of the patients with cryptogenic stroke have an
underlying malignancy. Stroke as a complication of cancer increases the morbidity and …

Cancer is an increasingly recognized cause for ischemic stroke, with recent
acknowledgement of cancer-related stroke as an emerging stroke subtype with unique …

Background Patients with cancer and acute ischemic stroke (AIS) face high rates of recurrent
thromboembolism or death. Objectives To examine whether hematologic and embolic …

Background and Purpose: Patients with acute stroke are often accompanied by
comorbidities, such as active cancer. However, adequate treatment guidelines are not …

Background and purpose This study aimed to evaluate the efficacy of intra-arterial
thrombectomy (IAT) and prognosis for acute ischaemic stroke patients with active cancer …